Cargando...

How Canadian Oncologists Use Oncotype DX for Treatment of Breast Cancer Patients

Background: The literature suggests that medical oncologists differ on how they use the Oncotype DX (ODX) genomic assay for making decisions about systemic therapy in breast cancer patients. Given the emergence of data supporting the use of genomic profiling for the prognosis and predicting benefit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Curr Oncol
Autores principales: Zhu, Xiaofu, Dent, Susan, Paquet, Lise, Zhang, Tinghua, Tesolin, Daniel, Graham, Nadine, Aseyev, Olexiy, Song, Xinni
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7985759/
https://ncbi.nlm.nih.gov/pubmed/33557029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/curroncol28010077
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!